Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:03:49.007Z.
Calculation as of: 2026-10-06T17:03:49.007Z.
Quote observation: 2026-10-06T16:53:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d2e468d5d1fee912cc594a855ce64a44190db3c5d14d549897f680d6209c50fe
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2023-05-15.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Precision Optics Corporation, Inc.
Market Cap
$47.83M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$48.23M
EV/EBIT Ratio
N/A
TTM Avg
11.96x
3Y Avg
9.90x
5Y Avg
11.19x
Market Cap
$50.13M
EV/EBIT Ratio
N/A
TTM Avg
36.45x
3Y Avg
39.02x
5Y Avg
39.02x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision Optics Corporation, Inc. (POCI) | $47.83M | N/A | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $48.66M | N/A | N/A | N/A | N/A |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.23M | N/A | 11.96x | 9.90x | 11.19x |
| Microbot Medical Inc. (MBOT)vs › | $50.13M | N/A | 36.45x | 39.02x | 39.02x |
| INmune Bio, Inc. (INMB)vs › | $50.25M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $45.37M | N/A | 17.26x | 19.56x | 25.78x |
| Apollomics, Inc. (APLM)vs › | $50.18M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $50.54M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $50.80M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2023-05-15 | 395.81x |
| 2023-05-12 | 372.88x |
| 2023-05-11 | 376.81x |
| 2023-05-10 | 378.59x |
| 2023-05-09 | 371.12x |
| 2023-05-08 | 371.12x |
| 2023-05-05 | 388.35x |
| 2023-05-04 | 375.72x |
| 2023-05-03 | 381.46x |
| 2023-05-02 | 375.72x |
| 2023-05-01 | 378.59x |
| 2023-04-28 | 384.33x |
| 2023-04-27 | 387.20x |
| 2023-04-26 | 382.20x |
| 2023-04-25 | 388.92x |
| 2023-04-24 | 390.07x |
| 2023-04-21 | 390.07x |
| 2023-04-20 | 398.69x |
| 2023-04-19 | 399.92x |
| 2023-04-18 | 397.66x |
| 2023-04-17 | 402.70x |
| 2023-04-14 | 398.69x |
| 2023-04-13 | 384.34x |
| 2023-04-12 | 381.46x |
| 2023-04-11 | 405.00x |
| 2023-04-10 | 405.00x |
| 2023-04-06 | 409.60x |
| 2023-04-05 | 412.47x |
| 2023-04-04 | 388.35x |
| 2023-04-03 | 390.07x |
| 2023-03-31 | 412.47x |
| 2023-03-30 | 390.65x |
| 2023-03-29 | 393.52x |
| 2023-03-28 | 371.12x |
| 2023-03-27 | 367.10x |
| 2023-03-24 | 367.10x |
| 2023-03-23 | 372.27x |
| 2023-03-22 | 372.27x |
| 2023-03-21 | 372.85x |
| 2023-03-20 | 371.12x |
| 2023-03-17 | 360.21x |
| 2023-03-16 | 409.02x |
| 2023-03-15 | 405.00x |
| 2023-03-14 | 435.43x |
| 2023-03-13 | 408.07x |
| 2023-03-10 | 397.54x |
| 2023-03-09 | 413.04x |
| 2023-03-08 | 432.28x |
| 2023-03-07 | 435.43x |
| 2023-03-06 | 431.99x |
| 2023-03-03 | 436.01x |
| 2023-03-02 | 433.14x |
| 2023-03-01 | 428.54x |
| 2023-02-28 | 427.40x |
| 2023-02-27 | 428.54x |
| 2023-02-24 | 425.67x |
| 2023-02-23 | 424.52x |
| 2023-02-22 | 424.52x |
| 2023-02-21 | 424.52x |
| 2023-02-17 | 423.95x |
| 2023-02-16 | 424.52x |
| 2023-02-15 | 421.37x |
